Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Prepaid Assets (2016 - 2025)

Protalix BioTherapeutics (PLX) has 12 years of Prepaid Assets data on record, last reported at $1.5 million in Q3 2025.

  • For Q3 2025, Prepaid Assets rose 38.29% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, up 38.29%, while the annual FY2024 figure was $1.1 million, 146.85% up from the prior year.
  • Prepaid Assets reached $1.5 million in Q3 2025 per PLX's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.0 million in Q2 2021 and bottomed at $444000.0 in Q4 2023.
  • Average Prepaid Assets over 5 years is $1.5 million, with a median of $1.5 million recorded in 2025.
  • Peak YoY movement for Prepaid Assets: tumbled 66.11% in 2023, then soared 146.85% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $1.3 million in 2021, then rose by 1.95% to $1.3 million in 2022, then crashed by 66.11% to $444000.0 in 2023, then skyrocketed by 146.85% to $1.1 million in 2024, then soared by 32.48% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $1.5 million in Q3 2025, $1.5 million in Q2 2025, and $1.6 million in Q1 2025.